Chrysin

Target genes for Chrysin is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
ChrysinNR1H3ATG_DR4_LXR_CIS_dn
ChrysinNACEETOX_H295R_PROG_up
ChrysinESR1CEETOX_H295R_ESTRONE_dn
ChrysinESR1CEETOX_H295R_ESTRADIOL_dn
ChrysinESR1CEETOX_H295R_TESTO_dn
ChrysinNACEETOX_H295R_TESTO_dn
ChrysinCYP19A1TOX21_Aromatase_Inhibition
ChrysinCYP24A1TOX21_VDR_BLA_antagonist_ratio
ChrysinAHRTOX21_AhR_LUC_Agonist
ChrysinAHRATG_Ahr_CIS_up
ChrysinESR1ATG_ERE_CIS_up
ChrysinESR1OT_ER_ERaERb_1440
ChrysinESR1ATG_ERa_TRANS_up
ChrysinESR1OT_ER_ERaERb_0480
ChrysinESR1TOX21_ERa_BLA_Agonist_ratio
ChrysinESR1CEETOX_H295R_ESTRONE_dn
ChrysinESR1TOX21_ERa_LUC_VM7_Agonist
ChrysinESR1TOX21_ERa_BLA_Antagonist_ratio
ChrysinESR1CEETOX_H295R_ESTRADIOL_dn
ChrysinESR2OT_ER_ERbERb_1440
ChrysinESR2OT_ER_ERbERb_0480
ChrysinESR2TOX21_ERb_BLA_Antagonist_ratio
ChrysinESR2CEETOX_H295R_ESTRONE_dn
ChrysinESR2CEETOX_H295R_ESTRADIOL_dn
ChrysinESR2OT_ER_ERaERb_1440
ChrysinESR2OT_ER_ERaERb_0480
ChrysinESRRATOX21_PGC_ERR_Agonist
ChrysinESRRATOX21_ERR_Agonist
ChrysinFOSATG_AP_1_CIS_dn
ChrysinNR3C1CEETOX_H295R_DOC_up
ChrysinNR3C1TOX21_GR_BLA_Antagonist_ratio
ChrysinNR3C1CEETOX_H295R_CORTIC_up
ChrysinHDAC1TOX21_HDAC_Inhibition
ChrysinARTOX21_AR_BLA_Antagonist_ratio
ChrysinARTOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881
ChrysinARCEETOX_H295R_TESTO_dn
ChrysinARACEA_AR_agonist_80hr
ChrysinJUNATG_AP_1_CIS_dn
ChrysinESR1CEETOX_H295R_ESTRONE_dn
ChrysinESR1CEETOX_H295R_ESTRADIOL_dn
ChrysinESR1CEETOX_H295R_TESTO_dn
ChrysinNACEETOX_H295R_ESTRONE_dn
ChrysinNACEETOX_H295R_ESTRADIOL_dn
ChrysinNACEETOX_H295R_TESTO_dn
ChrysinARCEETOX_H295R_TESTO_dn
ChrysinNR3C2CEETOX_H295R_CORTIC_up
ChrysinNR3C2CEETOX_H295R_DOC_up
ChrysinNFE2L2TOX21_ARE_BLA_agonist_ratio
ChrysinNFE2L2ATG_NRF2_ARE_CIS_up
ChrysinNFKB1ATG_NF_kB_CIS_up
ChrysinPGRCEETOX_H295R_PROG_up
ChrysinPGRCEETOX_H295R_OHPROG_up
ChrysinPGRCEETOX_H295R_OHPREG_up
ChrysinPGRTOX21_PR_BLA_Antagonist_ratio
ChrysinPPARAATG_PPRE_CIS_up
ChrysinPPARDTOX21_PPARd_BLA_antagonist_ratio
ChrysinPPARDATG_PPRE_CIS_up
ChrysinPPARGTOX21_PPARg_BLA_antagonist_ratio
ChrysinPPARGATG_PPRE_CIS_up
ChrysinPPARGATG_PPARg_TRANS_up
ChrysinPPARGTOX21_PPARg_BLA_Agonist_ratio
ChrysinTP53TOX21_p53_BLA_p2_ratio
ChrysinTP53TOX21_p53_BLA_p5_ratio
ChrysinTP53ATG_p53_CIS_up
ChrysinTP53TOX21_p53_BLA_p4_ratio
ChrysinNR1H2ATG_DR4_LXR_CIS_dn
ChrysinUSF1ATG_E_Box_CIS_dn
ChrysinVDRTOX21_VDR_BLA_antagonist_ratio
ChrysinNACEETOX_H295R_TESTO_dn
ChrysinNR1I3TOX21_CAR_Agonist
ChrysinNR1H4ATG_IR1_CIS_dn
ChrysinNR1H4TOX21_FXR_BLA_antagonist_ratio
ChrysinNR1H4OT_FXR_FXRSRC1_0480

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.